References:

American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders. https://doi.org/10.1176/appi.books.9780890425596
American Psychiatric Association. (2023). What is a substance use disorder? https://www.psychiatry.org/patients-families/addiction-substance-use-disorders/what-is-a-substance-use-disorder
Apsley, H. B., Santos-Lozada, A. R., Gray, J., Hard, G., & Jones, A. A. (2024). Substance Use Treatment Utilization Among Individuals With Substance Use Disorders in the United States During the COVID-19 Pandemic: Findings on the Role of Polysubstance Use, Criminal Justice Involvement, and Mental Illness From the National Survey on Drug Use and Health. Substance use : research and treatment, 18, 29768357241259947. https://doi.org/10.1177/29768357241259947
Bangasser, D. A., & Kawasumi, Y. (2015). Cognitive disruptions in stress-related psychiatric disorders: A role for corticotropin releasing factor (CRF). Hormones and Behavior, 76, 125–135. https://doi.org/10.1016/j.yhbeh.2015.04.003
Baumgartner, H. M., Granillo, M., Schulkin, J., & Berridge, K. C. (2022). Corticotropin releasing factor (CRF) systems: Promoting cocaine pursuit without distress via incentive motivation. PLOS ONE, 17(5), e0267345. https://doi.org/10.1371/journal.pone.0267345
Baumgartner, H. M., Schulkin, J., & Berridge, K. C. (2021). Activating corticotropin-releasing factor systems in the nucleus accumbens, amygdala, and bed nucleus of stria terminalis: Incentive motivation or aversive motivation? Biological Psychiatry, 89(12), 1162–1175. https://doi.org/10.1016/j.biopsych.2021.01.007
Becker, W. C., & Fiellin, D. A. (2017). Abuse-Deterrent Opioid Formulations - Putting the Potential Benefits into Perspective. New England Journal of Medicine, 376(22), 2103–2105. https://doi.org/10.1056/NEJMp1701553
Berridge, K. C., & Robinson, T. E. (2016). Liking, wanting, and the incentive-sensitization theory of addiction. The American Psychologist, 71(8), 670–679. https://doi.org/10.1037/amp0000059
Best, D., Lehmann, P., Gossop, M., Harris, J., Noble, A., & Strang, J. (1998). Eating too little, smoking and drinking too much: Wider lifestyle problems among methadone maintenance patients. Addiction Research, 6(6), 489–498. https://doi.org/10.3109/16066359809004367
Borges, C., Inigo, F., Quteishat, N., Charles, J., Ah-Yen, E., & Shalev, U. (2023). Acute food deprivation-induced relapse to heroin seeking after short and long punishment-imposed abstinence in male rats. Psychopharmacology, 240(3), 595–607. https://doi.org/10.1007/s00213-022-06207-4
Brown, S. A., Vik, P. W., Patterson, T. L., Grant, I., & Schuckit, M. A. (1995). Stress, vulnerability and adult alcohol relapse. Journal of Studies on Alcohol, 56(5), 538–545. https://doi.org/10.15288/jsa.1995.56.538
Bryce, C. A., & Floresco, S. B. (2016). Perturbations in effort-related decision-making driven by acute stress and corticotropin-releasing factor. Neuropsychopharmacology, 41(8), 2147–2159. https://doi.org/10.1038/npp.2016.15
Burman, S. (1997). The challenge of sobriety: natural recovery without treatment and self-help groups. Journal of Substance Abuse, 9(1), 41–61. https://doi.org/10.1016/S0899-3289(97)90005-5
Cabib, S., & Puglisi Allegra, S. (1996). Different effects of repeated stressful experiences on mesocortical and mesolimbic dopamine metabolism. Neuroscience, 73(2), 375–380. https://doi.org/10.1016/0306-4522(96)00750-6
Public Health Agency of Canada. (2024, August 20). 2024–2025 departmental plan. Government of Canada. https://www.canada.ca/en/public-health/corporate/transparency/corporate-management-reporting/reports-plans-priorities/2024-2025-departmental-plan.html
Carlson, R. G., Nahhas, R. W., Martins, S. S., & Daniulaityte, R. (2016). Predictors of transition to heroin use among initially non-opioid dependent illicit pharmaceutical opioid users: A natural history study. Drug and Alcohol Dependence, 160, 127–134. https://doi.org/10.1016/j.drugalcdep.2015.12.026
Carter, B. L., & Tiffany, S. T. (1999). Meta-analysis of cue-reactivity in addiction research. Addiction, 94(3), 327–340.
Centers for Disease Control and Prevention. (2016). Increases in drug and opioid overdose deaths—United States, 2000–2014. Morbidity and Mortality Weekly Report, 64(50–51), 1378–1382. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6450a3.htm
Cheskin, L. J., Hess, J. M., Henningfield, J., & Gorelick, D. A. (2005). Calorie restriction increases cigarette use in adult smokers. Psychopharmacology, 179(2), 430–436. https://doi.org/10.1007/S00213-004-2037-X/TABLES/1
Childress, A. R., Hole, A. V., Ehrman, R. N., Robbins, S. J., McLellan, A. T., & O'Brien, C. P. (1993). Cue reactivity and cue reactivity interventions in drug dependence. NIDA Research Monograph, 137, 73–95.
Cicero, T. J., Ellis, M. S., Surratt, H. L., & Kurtz, S. P. (2014). The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry, 71(7), 821–826. https://doi.org/10.1001/JAMAPSYCHIATRY.2014.366
Cook, J. L. (2022). The opioid epidemic. Best Practice & Research Clinical Obstetrics & Gynaecology, 85(Pt B), 53–58. https://doi.org/10.1016/j.bpobgyn.2022.07.003
Cooper, A., Barnea-Ygael, N., Levy, D., Shaham, Y., & Zangen, A. (2007). A conflict rat model of cue-induced relapse to cocaine seeking. Psychopharmacology, 194(1), 117–125. https://doi.org/10.1007/s00213-007-0827-7
Cullinan, W. E., Helmreich, D. L., & Watson, S. J. (1996). Fos expression in forebrain afferents to the hypothalamic paraventricular nucleus following swim stress. The Journal of Comparative Neurology, 368(1), 88–99. https://doi.org/10.1002/(SICI)1096-9861(19960422)368:1<88::AID-CNE6>3.0.CO;2-G
Cunningham, J. A., Lin, E., Ross, H. E., & Walsh, G. W. (2000). Factors associated with untreated remissions from alcohol abuse or dependence. Addictive Behaviors, 25(2), 317–321. https://doi.org/10.1016/S0306-4603(98)00130-0
Czeisler, M. É., Lane, R. I., Petrosky, E., Wiley, J. F., Christensen, A., Njai, R., Weaver, M. D., Robbins, R., Facer-Childs, E. R., Barger, L. K., Czeisler, C. A., Howard, M. E., & Rajaratnam, S. M. W. (2020). Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic - United States, June 24-30, 2020. MMWR. Morbidity and Mortality Weekly Report, 69(32), 1049–1057. https://doi.org/10.15585/mmwr.mm6932a1
Daviu, N. (2018). Behavior control of survival instincts.
D’Cunha, T. M., Sedki, F., MacRi, J., Casola, C., & Shalev, U. (2013). The effects of chronic food restriction on cue-induced heroin seeking in abstinent male rats. Psychopharmacology, 225(1), 241–250. https://doi.org/10.1007/S00213-012-2810-1
de Wit, H. (1996). Priming effects with drugs and other reinforcers. Experimental and Clinical Psychopharmacology, 4(1), 5–10. https://doi.org/10.1037/1064-1297.4.1.5
de Wit, H., & Stewart, J. (1983). Drug reinstatement of heroin-reinforced responding in the rat. Psychopharmacology, 79(1), 29–31. https://doi.org/10.1007/BF00433012
Deroche-Gamonet, V., Belin, D., & Piazza, P. V. (2004). Evidence for addiction-like behavior in the rat. Science, 305(5686), 1014–1017. https://doi.org/10.1126/science.1099020
Eisenberger, N. I. (2012). The neural bases of social pain: Evidence for shared representations with physical pain. Psychosomatic Medicine, 74(2), 126–135. https://doi.org/10.1097/PSY.0b013e3182464dd1
el-Nakah, A., Frank, O., Louria, D. B., Quinones, M. A., & Baker, H. (1979). A vitamin profile of heroin addiction. American Journal of Public Health, 69(10), 1058–1060. https://doi.org/10.2105/AJPH.69.10.1058
Epstein, D. H., Preston, K. L., Stewart, J., & Shaham, Y. (2006). Toward a model of drug relapse: An assessment of the validity of the reinstatement procedure. Psychopharmacology, 189(1), 1–16. https://doi.org/10.1007/s00213-006-0529-6
Erb, S., Shaham, Y., & Stewart, J. (1996). Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period. Psychopharmacology, 128(4), 408–412. https://doi.org/10.1007/s002130050150
Ferguson, A. V., Latchford, K. J., & Samson, W. K. (2008). The paraventricular nucleus of the hypothalamus - a potential target for integrative treatment of autonomic dysfunction. Expert Opinion on Therapeutic Targets, 12(6), 717–737. https://doi.org/10.1517/14728222.12.6.717
Fredriksson, I., Applebey, S. V., Minier-Toribio, A., Shekara, A., Bossert, J. M., & Shaham, Y. (2020). Effect of the dopamine stabilizer (-)-OSU6162 on potentiated incubation of opioid craving after electric barrier-induced voluntary abstinence. Neuropsychopharmacology, 45(5), 770–779. https://doi.org/10.1038/s41386-020-0602-6
Füzesi, T., Daviu, N., Wamsteeker Cusulin, J. I., Bonin, R. P., & Bains, J. S. (2016). Hypothalamic CRH neurons orchestrate complex behaviours after stress. Nature Communications, 7, 11937. https://doi.org/10.1038/ncomms11937
Gladden, R. M., Martinez, P., & Seth, P. (2016). Fentanyl law enforcement submissions and increases in synthetic opioid–involved overdose deaths — 27 states, 2013–2014. MMWR. Morbidity and Mortality Weekly Report, 65(33), 837–843. https://doi.org/10.15585/mmwr.mm6533a2
Hall, S. M., Tunstall, C. D., Vila, K. L., & Duffy, J. (1992). Weight gain prevention and smoking cessation: cautionary findings. American Journal of Public Health, 82(6), 799–803. https://doi.org/10.2105/AJPH.82.6.799
Hill, M. V., McMahon, M. L., Stucke, R. S., & Barth, R. J. Jr. (2017). Wide variation and excessive dosage of opioid prescriptions for common general surgical procedures. Annals of Surgery, 265(4), 709–714. https://doi.org/10.1097/SLA.0000000000001993
Hser, Y. I., Hoffman, V., Grella, C. E., & Anglin, M. D. (2001). A 33-year follow-up of narcotics addicts. Archives of General Psychiatry, 58(5), 503–508. https://doi.org/10.1001/archpsyc.58.5.503
Hunt, W. A., Barnett, L. W., & Branch, L. G. (1971). Relapse rates in addiction programs. Journal of Clinical Psychology, 27(4), 455–456. https://doi.org/10.1002/1097-4679(197110)27:4<455::aid-jclp2270270412>3.0.co;2-r
Jiang, Z., Rajamanickam, S., & Justice, N. J. (2019). CRF signaling between neurons in the paraventricular nucleus of the hypothalamus (PVN) coordinates stress responses. Neurobiology of Stress, 11, 100192. https://doi.org/10.1016/j.ynstr.2019.100192
Justice, N. J., Yuan, Z. F., Sawchenko, P. E., & Vale, W. (2008). Type 1 corticotropin-releasing factor receptor expression reported in BAC transgenic mice: Implications for reconciling ligand-receptor mismatch in the central corticotropin-releasing factor system. The Journal of Comparative Neurology, 511(4), 479–496. https://doi.org/10.1002/cne.21848
Kadam, M., Sinha, A., Nimkar, S., Matcheswalla, Y., & De Sousa, A. (2017). A Comparative Study of Factors Associated with Relapse in Alcohol Dependence and Opioid Dependence. Indian Journal of Psychological Medicine, 39(5), 627–633. https://doi.org/10.4103/IJPSYM.IJPSYM_356_17
Kalivas, P. W., & Stewart, J. (1991). Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Research Reviews, 16(3), 223–244. https://doi.org/10.1016/0165-0173(91)90007-U
Klingemann, H. K. (1991). The motivation for change from problem alcohol and heroin use. British Journal of Addiction, 86(6), 727–744. https://doi.org/10.1111/j.1360-0443.1991.tb03099.x
Koob, G. F. (2003). Alcoholism: allostasis and beyond. Alcoholism: Clinical and Experimental Research, 27(2), 232–243. https://doi.org/10.1097/01.ALC.0000057122.36127.C2
Koob, G. F., & Le Moal, M. (2005). Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nature neuroscience, 8(11), 1442–1444. https://doi.org/10.1038/nn1105-1442
Koob, G. F., & Schulkin, J. (2019). Addiction and stress: An allostatic view. Neuroscience and biobehavioral reviews, 106, 245–262. https://doi.org/10.1016/j.neubiorev.2018.09.008
Koob, G. F., & Volkow, N. D. (2016). Neurobiology of addiction: A neurocircuitry analysis. The Lancet Psychiatry, 3(8), 760–773. https://doi.org/10.1016/S2215-0366(16)00104-8
Larimer, M. E., Palmer, R. S., & Marlatt, G. A. (1999). Relapse prevention. An overview of Marlatt's cognitive-behavioral model. Alcohol Research & Health, 23(2), 151–160.
Lê, A. D., Harding, S., Juzytsch, W., Watchus, J., Shalev, U., & Shaham, Y. (2000). The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats. Psychopharmacology, 150(3), 317–324. https://doi.org/10.1007/s002130000411
Lê, A. D., Quan, B., Juzytch, W., Fletcher, P. J., Joharchi, N., & Shaham, Y. (1998). Reinstatement of alcohol-seeking by priming injections of alcohol and exposure to stress in rats. Psychopharmacology, 135(2), 169–174. https://doi.org/10.1007/s002130050498
Leung, P. T. M., Macdonald, E. M., Stanbrook, M. B., Dhalla, I. A., & Juurlink, D. N. (2017). A 1980 letter on the risk of opioid addiction. New England Journal of Medicine, 376(22), 2194–2195. https://doi.org/10.1056/nejmc1700150
Lopez-Quintero, C., Pérez de los Cobos, J., Hasin, D. S., Okuda, M., Wang, S., Grant, B. F., & Blanco, C. (2011). Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug and Alcohol Dependence, 115(1-2), 120–130. https://doi.org/10.1016/j.drugalcdep.2010.11.004
Makary, M. A., Overton, H. N., & Wang, P. (2017). Overprescribing is major contributor to opioid crisis. BMJ, 359. https://doi.org/10.1136/BMJ.J4792
Marlatt, G. A. (2002). Do animal models provide a valid analogue for human drug lapse and relapse? Comment on Leri and Stewart (2002). Experimental and Clinical Psychopharmacology, 10(4), 359–360. https://doi.org/10.1037/1064-1297.10.4.359
Marlatt, G. A., & Donovan, D. M. (Eds.). (2005). Relapse prevention: Maintenance strategies in the treatment of addictive behaviors (2nd ed.). The Guilford Press.
Mars, S. G., Bourgois, P., Karandinos, G., Montero, F., & Ciccarone, D. (2014). "Every 'never' I ever said came true": transitions from opioid pills to heroin injecting. The International Journal on Drug Policy, 25(2), 257–266. https://doi.org/10.1016/j.drugpo.2013.10.004
Mantsch, J. R. (2022). Corticotropin releasing factor and drug seeking in substance use disorders: preclinical evidence and translational limitations. Addiction Neuroscience, 4, 100038. https://doi.org/10.1016/j.addicn.2022.100038
Mantsch, J. R., Baker, D. A., Funk, D., Lê, A. D., & Shaham, Y. (2016). Stress-induced reinstatement of drug seeking: 20 years of progress. Neuropsychopharmacology, 41(1), 335–356. https://doi.org/10.1038/npp.2015.142
McAuliffe, W. E., & Gordon, R. A. (1980). Reinforcement and the combination of effects: summary of a theory of opiate addiction. NIDA Research Monograph, 30, 137–141.
McFarland, K., Davidge, S. B., Lapish, C. C., & Kalivas, P. W. (2004). Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior. The Journal of Neuroscience, 24(7), 1551–1560. https://doi.org/10.1523/JNEUROSCI.4177-03.2004
McNeely, J., Wu, L. T., Subramaniam, G., Sharma, G., Cathers, L. A., Svikis, D., Sleiter, L., Russell, L., Nordeck, C., Sharma, A., O'Grady, K. E., Bouk, L. B., Cushing, C., King, J., Wahle, A., & Schwartz, R. P. (2016). Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients. Annals of Internal Medicine, 165(10), 690–699. https://doi.org/10.7326/M16-0317
Mercier, S., Canini, F., Buguet, A., Cespuglio, R., Martin, S., & Bourdon, L. (2003). Behavioural changes after an acute stress: stressor and test types influences. Behavioural Brain Research, 139(1–2), 167–175. https://doi.org/10.1016/S0166-4328(02)00265-6
Miller, T. W. (Ed.). (1996). Theory and assessment of stressful life events. International Universities Press, Inc.
Moscarello, J. M., Ben-Shahar, O., & Ettenberg, A. (2009). Effects of food deprivation on goal-directed behavior, spontaneous locomotion, and c-Fos immunoreactivity in the amygdala. Behavioural Brain Research, 197(1), 9–15. https://doi.org/10.1016/J.BBR.2008.07.025
Neale, J., Nettleton, S., Pickering, L., & Fischer, J. (2012). Eating patterns among heroin users: a qualitative study with implications for nutritional interventions. Addiction (Abingdon, England), 107(3), 635–641. https://doi.org/10.1111/j.1360-0443.2011.03660.x
Noble, C., & McCombie, L. (1997). Nutritional considerations in intravenous drug misusers: a review of the literature and current issues for dietitians. Journal of Human Nutrition and Dietetics, 10(3), 181–191. https://doi.org/10.1046/j.1365-277X.1997.00051.x
O’Donnell, J. K., Gladden, R. M., & Seth, P. (2017). Trends in deaths involving heroin and synthetic opioids excluding methadone, and law enforcement drug product reports, by Census Region — United States, 2006–2015. MMWR Morbidity and Mortality Weekly Report, 66(34), 897–903. https://doi.org/10.15585/mmwr.mm6634a2
Ouzir, M., & Errami, M. (2016). Etiological theories of addiction: A comprehensive update on neurobiological, genetic and behavioural vulnerability. Pharmacology, Biochemistry, and Behavior, 148, 59–68. https://doi.org/10.1016/j.pbb.2016.06.005
Pecoraro, N., Reyes, F., Gomez, F., Bhargava, A., & Dallman, M. F. (2004). Chronic stress promotes palatable feeding, which reduces signs of stress: feedforward and feedback effects of chronic stress. Endocrinology, 145(8), 3754–3762. https://doi.org/10.1210/en.2004-0305
Peciña, S., Schulkin, J., & Berridge, K. C. (2006). Nucleus accumbens corticotropin-releasing factor increases cue-triggered motivation for sucrose reward: paradoxical positive incentive effects in stress? BMC Biology, 4, 8. https://doi.org/10.1186/1741-7007-4-8
Pelloux, Y., Everitt, B. J., & Dickinson, A. (2007). Compulsive drug seeking by rats under punishment: effects of drug taking history. Psychopharmacology, 194(1), 127–137. https://doi.org/10.1007/s00213-007-0805-0
Pomrenze, M. B., & Marinelli, M. (2021). Love it or leave it: Differential modulation of incentive motivation by corticotropin-releasing factor neurons. Biological Psychiatry, 89(12), 1113–1115. https://doi.org/10.1016/j.biopsych.2021.03.032
Preston, K. L., & Epstein, D. H. (2011). Stress in the daily lives of cocaine and heroin users: Relationship to mood, craving, relapse triggers, and cocaine use. Psychopharmacology, 218(1), 29–37. https://doi.org/10.1007/s00213-011-2183-x
Ramot, A., Jiang, Z., Tian, J. B., Nahum, T., Kuperman, Y., Justice, N., & Chen, A. (2017). Hypothalamic CRFR1 is essential for HPA axis regulation following chronic stress. Nature Neuroscience, 20(3), 385–388. https://doi.org/10.1038/nn.4491
Reiner, D. J., Fredriksson, I., Lofaro, O. M., Bossert, J. M., & Shaham, Y. (2019). Relapse to opioid seeking in rat models: Behavior, pharmacology and circuits. Neuropsychopharmacology, 44(3), 465–477. https://doi.org/10.1038/s41386-018-0234-2
Ritchie, J. L., Walters, J. L., Galliou, J. M. C., Christian, R. J., Qi, S., Savenkova, M. I., Ibarra, C. K., Grogan, S. R., & Fuchs, R. A. (2021). Basolateral amygdala corticotropin-releasing factor receptor type 1 regulates context cocaine memory strength during reconsolidation in a sex dependent manner. Neuropharmacology, 200, 108819. https://doi.org/10.1016/j.neuropharm.2021.108819
Rodaros, D., Caruana, D. A., Amir, S., & Stewart, J. (2007). Corticotropin-releasing factor projections from limbic forebrain and paraventricular nucleus of the hypothalamus to the region of the ventral tegmental area. Neuroscience, 150(1), 8–13. https://doi.org/10.1016/j.neuroscience.2007.09.043
Scher, C., Meador, L., Van Cleave, J. H., & Reid, M. C. (2018). Moving beyond pain as the fifth vital sign and patient satisfaction scores to improve pain care in the 21st century. Pain Management Nursing, 19(2), 125–129. https://doi.org/10.1016/j.pmn.2017.10.010
Sedki, F., Abbas, Z., Angelis, S., Martin, J., D’Cunha, T., & Shalev, U. (2013). Is it stress? the role of stress related systems in chronic food restriction-induced augmentation of heroin seeking in the rat. Frontiers in Neuroscience, 7, 98. https://doi.org/10.3389/fnins.2013.00098
Shaham, Y., Funk, D., Erb, S., Brown, T. J., Walker, C. D., & Stewart, J. (1997). Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. The Journal of Neuroscience, 17(7), 2605–2614. https://doi.org/10.1523/JNEUROSCI.17-07-02605.1997
Shaham, Y., Shalev, U., Lu, L., de Wit, H., & Stewart, J. (2003). The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl), 168(1-2), 3–20. https://doi.org/10.1007/s00213-002-1224-x
Shaham, Y., & Stewart, J. (1995). Stress reinstates heroin-seeking in drug-free animals: an effect mimicking heroin, not withdrawal. Psychopharmacology, 119(3), 334–341. https://doi.org/10.1007/BF02246300
Shalev, U. (2012). Chronic food restriction augments the reinstatement of extinguished heroin-seeking behavior in rats. Addiction Biology, 17(4), 691–693. https://doi.org/10.1111/J.1369-1600.2010.00303.X
Shalev, U., Finnie, P. S., Quinn, T., Tobin, S., & Wahi, P. (2006). A role for corticotropin-releasing factor, but not corticosterone, in acute food-deprivation-induced reinstatement of heroin seeking in rats. Psychopharmacology, 187(3), 376–384. https://doi.org/10.1007/s00213-006-0427-y
Shalev, U., Highfield, D., Yap, J., & Shaham, Y. (2000). Stress and relapse to drug seeking in rats: Studies on the generality of the effect. Psychopharmacology, 150(3), 337–346. https://doi.org/10.1007/S002130000441
Shalev, U., Marinelli, M., Baumann, M. H., Piazza, P. V., & Shaham, Y. (2003). The role of corticosterone in food deprivation-induced reinstatement of cocaine seeking in the rat. Psychopharmacology, 168(1-2), 170–176. https://doi.org/10.1007/s00213-002-1200-5
Shalev, U., Yap, J., & Shaham, Y. (2001). Leptin attenuates acute food deprivation-induced relapse to heroin seeking. The Journal of neuroscience : the official journal of the Society for Neuroscience, 21(4), RC129. https://doi.org/10.1523/JNEUROSCI.21-04-j0001.2001
Shalev, A. Y., Tuval, R., Frenkiel Fishman, S., Hadar, H., & Eth, S. (2006). Psychological responses to continuous terror: a study of two communities in Israel. The American Journal of Psychiatry, 163(4), 667–673. https://doi.org/10.1176/ajp.2006.163.4.667
Sinha, R. (2001). How does stress increase risk of drug abuse and relapse? Psychopharmacology, 158(4), 343–359. https://doi.org/10.1007/s002130100917
Smyth, B. P., Barry, J., Keenan, E., & Ducray, K. (2010). Lapse and relapse following inpatient treatment of opiate dependence. Irish Medical Journal, 103(6), 176–179.
Spencer, M., Miniño, A., & Warner, M. (2024). Drug overdose deaths in the United States, 2001–2021. https://doi.org/10.15620/CDC:122556
Stewart, J., & de Wit, H. (1987). Reinstatement of drug-taking behavior as a method of assessing incentive motivational properties of drugs. In Methods of assessing the reinforcing properties of abused drugs (pp. 211–227). https://doi.org/10.1007/978-1-4612-4812-5_12
Tovar-Díaz, J., Pomrenze, M. B., Kan, R., Pahlavan, B., & Morikawa, H. (2018). Cooperative CRF and α1 adrenergic signaling in the VTA promotes NMDA plasticity and drives social stress enhancement of cocaine conditioning. Cell Reports, 22(10), 2756–2766. https://doi.org/10.1016/j.celrep.2018.02.039
Ungless, M. A., Singh, V., Crowder, T. L., Yaka, R., Ron, D., & Bonci, A. (2003). Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons. Neuron, 39(3), 401–407. https://doi.org/10.1016/S0896-6273(03)00461-6
Venniro, M., Caprioli, D., & Shaham, Y. (2016). Animal models of drug relapse and craving: From drug priming-induced reinstatement to incubation of craving after voluntary abstinence. Prog Brain Res, 224, 25–52. https://doi.org/10.1016/bs.pbr.2015.08.004
Volkow, N. D., & Blanco, C. (2023). Substance use disorders: A comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention. World Psychiatry, 22(2), 203–229. https://doi.org/10.1002/wps.21073
Volkow, N. D., & Morales, M. (2015). The brain on drugs: From reward to addiction. Cell, 162(4), 712–725. https://doi.org/10.1016/j.cell.2015.07.046
Wang, B., Shaham, Y., Zitzman, D., Azari, S., Wise, R. A., & You, Z. B. (2005). Cocaine experience establishes control of midbrain glutamate and dopamine by corticotropin-releasing factor: A role in stress-induced relapse to drug seeking. The Journal of Neuroscience, 25(22), 5389–5396. https://doi.org/10.1523/JNEUROSCI.0955-05.2005
World Health Organization. (2023, August 29). Opioid overdose (Fact sheet). https://www.who.int/news-room/fact-sheets/detail/opioid-overdose
Xu, X., Zheng, S., Ren, J., Li, Z., Li, J., Xu, Z., Yuan, F., Yang, Q., Margetts, A. V., Pollock, T. A., Vilca, S. J., Yang, C., Chen, G., Shen, P., Li, S., Xia, J., Chen, C., Zhou, T., Zhu, Y., Tuesta, L. M., … Chen, Z. (2024). Hypothalamic CRF neurons facilitate brain reward function. Current Biology, 34(2), 389–402.e5. https://doi.org/10.1016/j.cub.2023.12.046